Cargando…
Autoimmune hepatitis following SARS-CoV-2 vaccine: May not be a casuality
Autores principales: | Rocco, Alba, Sgamato, Costantino, Compare, Debora, Nardone, Gerardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186938/ https://www.ncbi.nlm.nih.gov/pubmed/34116081 http://dx.doi.org/10.1016/j.jhep.2021.05.038 |
Ejemplares similares
-
Autoimmune liver diseases and SARS-CoV-2
por: Sgamato, Costantino, et al.
Publicado: (2023) -
Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives
por: Rocco, Alba, et al.
Publicado: (2021) -
Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome
por: Compare, Debora, et al.
Publicado: (2017) -
Blinded Oral Challenges with Lactose and Placebo Accurately Diagnose Lactose Intolerance: A Real-Life Study
por: Rocco, Alba, et al.
Publicado: (2021) -
Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination
por: Rigamonti, C., et al.
Publicado: (2022)